IPCS INCHEM Home

    GLUCOSE ISOMERASE (IMMOBILIZED) FROM BACILLUS COAGULANS

    EXPLANATION

         This enzyme preparation has not been previously evaluated by the
    Joint FAO/WHO Expert Committee on Food Additives.

    BIOLOGICAL DATA

    Biochemical aspects

         No studies available.

    Toxicological studies

    Special study on mutagenicity

    Rats

         A dominant lethal study was carried out using Sprague-Dawley
    rats. Groups of 12 or 15 males were dosed twice daily for 5
    consecutive days by gavage with immobilized glucose isomerase in an
    aqueous 0.5% tragacanth gum suspension such that they received a total
    daily dose of 0, 3000, or 9000 mg/kg b.w. of the enzyme. A positive
    control group of 11 males received 3 mg/kg b.w. of thiotepa per day by
    i.p. injection. On the sixth day following treatment, each male was
    housed with two females. Every 7 days, 2 new females were paired with
    every male, and the procedure continued for a total of 10 weeks. Half
    of the females were sacrificed on day 5 of gestation, and the other
    half on day 21. A slight reduction in testicular weights was observed
    in high-dose males and a significant increase in pre-implantation
    losses occurred in low-dose, but not high-dose females in the 10-week
    mating. No compound-related effects were observed with respect to
    weight gain in males, fertilization index, development of fertilized
    ova, or post-implantation loss (Tesh, 1976).

    Special study on reproduction

    Rats

         A 3-generation reproduction study was carried out using groups of
    15 male and 30 female Sprague-Dawley rats given 0, 0.5, 1.0, or 5.0%
    immobilized glucose isomerase in the diet. These dietary
    concentrations were given for 70 days prior to and through mating (on
    a 1 male to 2 female basis) and throughout 2 successive pregnancies in
    each of 3 generations. The litters arising from the first pregnancy
    were sacrificed after 14 days of lactation and the second litter of
    each generation stayed with the dam until weaning, when 15 males and
    30 females were selected at random to produce the succeeding
    generation. After each round of mating had been completed, 5 pregnant

    females from each group were sacrificed at day 14 of gestation for
    examination of uterine contents. A total of 20 males and 20 females
    from the F3b litter were sacrificed after weaning for gross and
    microscopic pathological examination. No compound-related effects were
    reported on body-weight gain of parental animals of either sex, food
    consumption, litter weights, mating performance, reproductive indices,
    foetal development, or gross or microscopic pathology. There was an
    increased incidence of females with irregular estrous cycles and
    increased pre-coital intervals in the mid- and high-dose groups.
    However, there was no effect on reproductive performance in these
    groups. There was a slight increase in gonadal weights in the mid- and
    high-dose F3b males, but no gross or microscopic changes related to
    treatment were found (Tesh & Smith, 1976).

    Special studies on teratogenicity

    Rats

         Groups of 20 pregnant female CD rats were fed diets containing 0,
    0.5, 1.0, or 5.0% immobilized glucose isomerase in the diet from days
    6 through 15 of gestation. The animals were sacrificed on day 21 of
    pregnancy; one-third of the foetuses were processed for examination of
    soft tissue anomalies and the remaining foetuses were processed for
    examination of skeletal abnormalities. There was an increase in pre-
    implantation loss in the high-dose group; however, no effect was
    reported on the number of viable foetuses, and the pre-implantation
    effect seemed to be due to an increase in corpora lutea in the high-
    dose rats (Tesh et al., 1975).

    Rabbits

         Groups of 20 pregnant New Zealand-strain rabbits were dosed by
    gavage with 0, 250, 500, or 750 mg/kg b.w. immobilized glucose
    isomerase (in an aqueous 0.5% tragacanth-gum vehicle) from days 6
    through 18 of pregnancy. The animals were sacrificed on day 29 of
    pregnancy. Foetuses were examined internally and externally and then
    processed for skeletal examination. No compound-related effects were
    observed on maternal weight-gain, pre- or post-implantation loss,
    litter size, foetal weight or foetal anomalies (Tesh & Toseland,
    1975).

    Acute toxicity
                                                            
                                LD50
    Species    Route          (mg/kg b.w.)   Reference
                                                            

    Mouse      oral (gavage)  6,000          Novo, 1974a
    Rat        oral (gavage)  6,000          Novo, 1974b
    Dog        oral (gavage)  5,000          Novo, 1975
                                                            

    Short-term studies

    Rats

         Groups of five female Wistar rats were fed diets containing 0, 1,
    or 10% immobilized glucose isomerase for 4 weeks. Weight gain was
    slightly greater in the treated animals and feed intake was
    significantly higher in males and females in both treatment groups.
    Feed conversion efficiency was slightly reduced in dosed females
    during the latter half of the study. Haemoglobin concentrations were
    lower in treated as compared to control animals; however, this was
    attributed to abnormally high values in the control group. No
    treatment-related changes were reported with respect to clinical
    chemistry, absolute and relative organ weights, or gross and
    microscopic pathology (Novo, 1974c).

         Groups of 15 male and 15 female Sprague-Dawley rats were given
    diets containing 0, 0.5, 1.0, or 5.0% immobilized glucose isomerase
    for 13 weeks. No significant compound-related effects were reported
    with regard to body-weight gain, feed consumption, haematology, blood
    chemistry, urinalysis, opthalmoscopy, absolute or relative organ-
    weights, or gross pathology. There was an increase in incidence and
    size of focal mineralization in the kidneys of treated females as
    opposed to controls. No other compound-related histological changes
    were observed.

         Another study was performed to investigate the cause of the renal
    mineralization. Groups of 15 female Sprague-Dawley rats were fed one
    of two different commercial laboratory diets containing 0, 0.1, 1.0,
    or 5.0% immobilized glucose isomerase. Body-weight gain, urinalysis,
    organ weights, and gross pathology were not significantly affected by
    treatment. There was no effect of treatment on animals fed one of the
    laboratory diets. In the animals fed the other diet, the incidence of
    focal mineralization was greater in the high-dose group than in the
    controls, but the other dose groups did not show a treatment-related
    effect (Wheldon & Ben-Dyke, 1975).

    Dogs

         Groups of 3 male and 3 female beagle dogs were fed diets
    containing 0, 0.5, 1.0, or 5.0% immobilized glucose isomerase in the
    diet for 13 weeks. No compound-related effects were observed with
    respect to body-weight gain, ophthalmoscopy, haematology, blood and
    urine chemistry, organ weights, or gross or microscopic pathology
    (Wheldon & Ben-Dyke, 1975).

    Long-term studies

         No information available.

    Observations in man

         No information available.

    Comments

         The focal mineralization of the kidney of the rat in one study
    was restricted to females receiving 5% of the enzyme preparation.
    Females fed a different laboratory diet containing 5% of the enzyme
    preparation did not exhibit this lesion. No other significant
    compound-related effects were observed in either rat study. No adverse
    effects were observed in a short-term feeding study in dogs,
    teratology studies in rats and rabbits, or reproduction and dominant
    lethal studies in rats.

    EVALUATION

    Level causing no toxicological effect

    Rat: 5% (50,000 ppm) in the diet, equivalent to 5000 mg/kg b.w./day.

    Estimate of acceptable daily intake for man

    Acceptable for use in food processing when used as a component in an
    immobilized system.

    REFERENCES

    Novo (1974a). Acute oral toxicity of SP113 to mice. Unpublished report
         of Novo Industria A/S. Submitted to the World Health Organization
         by Novo Industria A/S.

    Novo (1974b). Acute oral toxicity of SP113 to rats. Unpublished report
         of Novo Industria A/S. Submitted to the World Health Organization
         by Novo Industria A/S.

    Novo (1974c). Four week oral toxicity study of glucose isomerase
         (SP113) in rats. Unpublished report of Novo Industria A/S.
         Submitted to the World Health Organization by Novo Industria A/S.

    Novo (1975). Acute toxicity of glucose isomerase-SP113 given once
         perorally to Beagle dogs. Unpublished report of Novo Industria
         A/S. Submitted to the World Health Organization by Novo Industria
         A/S.

    Tesh, J.M. (1976). SP113: Dominant lethal study in rats. Unpublished
         report of Life Science Research. Submitted to the World Health
         Organization by Novo Industria A/S.

    Tesh, J.M. & Smith, C. (1976). SP113: Multigeneration study in rats.
         Unpublished report of Life Science Research. Submitted to the
         World Health Organization by Novo Industria A/S.

    Tesh, J.M. & Toseland, A.E. (1975). SP113: Effects upon pregnancy in
         the rabbit. Unpublished report of Life Science Research.
         Submitted to the World Health Organization by Novo Industria A/S.

    Tesh, J.M., Toseland, A.E., & Pinson, C.D. (1975). SP113: Effects upon
         pregnancy in the rat. Unpublished report of Life Science
         Research. Submitted to the World Health Organization by Novo
         Industria A/S.

    Wheldon, G.H., Ben-Dyke, R., Perry, M.C., & Newman, A.J. (1975).
         SP113: Toxicity in continuous dietary administration to rats for
         13 weeks. Unpublished report of Life Science Research. Submitted
         to the World Health Organization by Novo Industria A/S.

    Wheldon, G.H., & Ben-Dyke, R. (1975). SP113: Toxicity in dietary
         administration to dogs over 13 weeks. Unpublished report of Life
         Science Research. Submitted to the World Health Organization by
         Novo Industria A/S.
    


    See Also:
       Toxicological Abbreviations